» Articles » PMID: 16520860

Nonheart Failure-associated Elevation of Amino Terminal Pro-brain Natriuretic Peptide in the Setting of Sepsis

Overview
Journal Can J Cardiol
Publisher Elsevier
Date 2006 Mar 8
PMID 16520860
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

In addition to its importance in clinical assessment, N-terminal pro-brain natriuretic peptide (NT pro-BNP) is a valuable marker for evaluation of treatment and prognosis of heart failure. However, there are situations where NT pro-BNP is not related to myocardial dysfunction. Two cases of sepsis with markedly elevated NT pro-BNP levels that are not indicative of depressed myocardial function are described.

Citing Articles

Diastolic Dysfunction with Normal Ejection Fraction and Reduced Heart Rate in Mice Expressing Human Growth Hormone and Displaying Signs of Growth Hormone Insufficiency.

Jin Y, Xiang B, Dolinsky V, Kardami E, Cattini P Int J Mol Sci. 2025; 26(1.

PMID: 39796124 PMC: 11719473. DOI: 10.3390/ijms26010269.


NT-proBNP point-of-care testing for predicting mortality in end-stage renal disease: A survival analysis.

Chen C, Hsu Y, Chou K, Chang K, Hsu Y, Chiu W Heliyon. 2024; 10(9):e30581.

PMID: 38742053 PMC: 11089362. DOI: 10.1016/j.heliyon.2024.e30581.


Prognosis Implication of N-Terminal Pro-B-Type Natriuretic Peptide in Adult Patients With Acute Myocarditis.

Zhao Y, Lyu N, Zhang W, Tan H, Jin Q, Dang A Front Cardiovasc Med. 2022; 9:839763.

PMID: 35433855 PMC: 9009355. DOI: 10.3389/fcvm.2022.839763.


Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology.

Bonaca M, Olenchock B, Salem J, Wiviott S, Ederhy S, Cohen A Circulation. 2019; 140(2):80-91.

PMID: 31390169 PMC: 6779326. DOI: 10.1161/CIRCULATIONAHA.118.034497.


Can NT-pro BNP Levels Predict Prognosis of Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?.

Ediboglu O, Kirakli C Balkan Med J. 2018; 35(6):422-426.

PMID: 29966999 PMC: 6251376. DOI: 10.4274/balkanmedj.2018.0006.


References
1.
JAFRI S, Lavine S, Field B, Bahorozian M, Carlson R . Left ventricular diastolic function in sepsis. Crit Care Med. 1990; 18(7):709-14. DOI: 10.1097/00003246-199007000-00005. View

2.
Chua G, Kang-Hoe L . Marked elevations in N-terminal brain natriuretic peptide levels in septic shock. Crit Care. 2004; 8(4):R248-50. PMC: 522851. DOI: 10.1186/cc2889. View

3.
de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C . B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol. 2004; 43(9):1584-9. DOI: 10.1016/j.jacc.2003.11.059. View

4.
Stewart S, Macintyre K, Hole D, Capewell S, McMurray J . More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail. 2001; 3(3):315-22. DOI: 10.1016/s1388-9842(00)00141-0. View

5.
Fitch S, Gossage J . Optimal management of septic shock. Rapid recognition and institution of therapy are crucial. Postgrad Med. 2002; 111(3):53-6, 59-60, 63-4 passim. DOI: 10.3810/pgm.2002.03.1133. View